{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T22:39:51Z","timestamp":1785796791670,"version":"3.56.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"S14","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Bioinformatics"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1186\/s12859-018-2379-8","type":"journal-article","created":{"date-parts":[[2018,11,16]],"date-time":"2018-11-16T10:30:51Z","timestamp":1542364251000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["TMFUF: a triple matrix factorization-based unified framework for predicting comprehensive drug-drug interactions of new drugs"],"prefix":"10.1186","volume":"19","author":[{"given":"Jian-Yu","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Ning","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siu-Ming","family":"Yiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,20]]},"reference":[{"issue":"10","key":"2379_CR1","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1038\/nrd1851","volume":"4","author":"LC Wienkers","year":"2005","unstructured":"Wienkers LC, Heath TG. Predicting in vivo drug interactions from in vitro drug discovery data. Nat Rev Drug Discov. 2005;4(10):825\u201333.","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"2379_CR2","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1001\/jama.1995.03530010049034","volume":"274","author":"LL Leape","year":"1995","unstructured":"Leape LL, Bates DW, Cullen DJ, Cooper J, Demonaco HJ, Gallivan T, Hallisey R, Ives J, Laird N, Laffel G, et al. Systems analysis of adverse drug events. ADE prevention study group. JAMA. 1995;274(1):35\u201343.","journal-title":"JAMA"},{"key":"2379_CR3","first-page":"4","volume":"1","author":"R Businaro","year":"2013","unstructured":"Businaro R. Why we need an efficient and careful pharmacovigilance. Aust J Pharm. 2013;1:4.","journal-title":"Aust J Pharm"},{"key":"2379_CR4","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.ejps.2017.02.028","volume":"102","author":"A Karbownik","year":"2017","unstructured":"Karbownik A, Sza\u0142ek E, Soba\u0144ska K, Grabowski T, Wolc A, Grze\u015bkowiak E. Pharmacokinetic drug-drug interaction between erlotinib and paracetamol: a potential risk for clinical practice. Eur J Pharm Sci. 2017;102:55\u201362.","journal-title":"Eur J Pharm Sci"},{"issue":"1450","key":"2379_CR5","first-page":"102","volume":"130","author":"E Mulroy","year":"2017","unstructured":"Mulroy E, Highton J, Jordan S. Giant cell arteritis treatment failure resulting from probable steroid\/antiepileptic drug-drug interaction. N Z Med J. 2017;130(1450):102\u20134.","journal-title":"N Z Med J"},{"issue":"11","key":"2379_CR6","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1038\/nbt.1581","volume":"27","author":"H Veith","year":"2009","unstructured":"Veith H, Southall N, Huang R, James T, Fayne D, Artemenko N, Shen M, Inglese J, Austin CP, Lloyd DG, et al. Comprehensive characterization of cytochrome P450 isozyme selectivity across chemical libraries. Nat Biotechnol. 2009;27(11):1050\u20135.","journal-title":"Nat Biotechnol"},{"issue":"2","key":"2379_CR7","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/sj.clpt.6100054","volume":"81","author":"SM Huang","year":"2007","unstructured":"Huang SM, Temple R, Throckmorton DC, Lesko LJ. Drug interaction studies: study design, data analysis, and implications for dosing and labeling. Clin Pharmacol Ther. 2007;81(2):298\u2013304.","journal-title":"Clin Pharmacol Ther"},{"key":"2379_CR8","doi-asserted-by":"publisher","first-page":"12339","DOI":"10.1038\/srep12339","volume":"5","author":"P Zhang","year":"2015","unstructured":"Zhang P, Wang F, Hu J, Sorrentino R. Label propagation prediction of drug-drug interactions based on clinical side effects. Sci Rep. 2015;5:12339.","journal-title":"Sci Rep"},{"issue":"6","key":"2379_CR9","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s40495-016-0075-9","volume":"2","author":"B Wi\u015bniowska","year":"2016","unstructured":"Wi\u015bniowska B, Polak S. The role of interaction model in simulation of drug interactions and QT prolongation. Curr Pharmacol Rep. 2016;2(6):339\u201344.","journal-title":"Curr Pharmacol Rep"},{"issue":"5","key":"2379_CR10","first-page":"250","volume":"5","author":"D Zhou","year":"2016","unstructured":"Zhou D, Bui K, Sostek M, Al-Huniti N. Simulation and prediction of the drug-drug interaction potential of Naloxegol by physiologically based pharmacokinetic modeling. CPT: Pharmacometrics Syst Pharmacol. 2016;5(5):250\u20137.","journal-title":"CPT: Pharmacometrics Syst Pharmacol"},{"issue":"23","key":"2379_CR11","doi-asserted-by":"publisher","first-page":"3365","DOI":"10.1093\/bioinformatics\/btu557","volume":"30","author":"QC Bui","year":"2014","unstructured":"Bui QC, Sloot PMA, van Mulligen EM, Kors JA. A novel feature-based approach to extract drug-drug interactions from biomedical text. Bioinformatics. 2014;30(23):3365\u201371.","journal-title":"Bioinformatics"},{"issue":"Suppl 3","key":"2379_CR12","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s12918-016-0311-2","volume":"10","author":"Y Zhang","year":"2016","unstructured":"Zhang Y, Wu HY, Xu J, Wang J, Soysal E, Li L, Xu H. Leveraging syntactic and semantic graph kernels to extract pharmacokinetic drug drug interactions from biomedical literature. BMC Syst Biol. 2016;10(Suppl 3):67.","journal-title":"BMC Syst Biol"},{"issue":"8","key":"2379_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1002614","volume":"8","author":"JD Duke","year":"2012","unstructured":"Duke JD, Han X, Wang ZP, Subhadarshini A, Karnik SD, Li XC, Hall SD, Jin Y, Callaghan JT, Overhage MJ, et al. Literature based drug interaction prediction with clinical assessment using electronic medical records: novel myopathy associated drug interactions. PLoS Comput Biol. 2012;8(8):e1002614.","journal-title":"PLoS Comput Biol"},{"issue":"9","key":"2379_CR14","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1038\/nprot.2014.151","volume":"9","author":"S Vilar","year":"2014","unstructured":"Vilar S, Uriarte E, Santana L, Lorberbaum T, Hripcsak G, Friedman C, Tatonetti NP. Similarity-based modeling in large-scale prediction of drug-drug interactions. Nat Protoc. 2014;9(9):2147\u201363.","journal-title":"Nat Protoc"},{"issue":"e2","key":"2379_CR15","first-page":"e278","volume":"21","author":"F Cheng","year":"2014","unstructured":"Cheng F, Zhao Z. Machine learning-based prediction of drug-drug interactions by integrating drug phenotypic, therapeutic, chemical, and genomic properties. JAMIA: J Am Med Inform Assoc. 2014;21(e2):e278\u201386.","journal-title":"JAMIA: J Am Med Inform Assoc"},{"key":"2379_CR16","doi-asserted-by":"publisher","first-page":"Web Server issu","DOI":"10.1093\/nar\/gku433","volume":"42","author":"H Luo","year":"2014","unstructured":"Luo H, Zhang P, Huang H, Huang J, Kao E, Shi L, He L, Yang L. DDI-CPI, a server that predicts drug-drug interactions through implementing the chemical-protein interactome. Nucleic Acids Res. 2014;42:Web Server issue):46\u201352.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"2379_CR17","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/00007691-198109000-00002","volume":"3","author":"J Koch-Weser","year":"1981","unstructured":"Koch-Weser J. Serum drug concentrations in clinical perspective. Ther Drug Monit. 1981;3(1):3\u201316.","journal-title":"Ther Drug Monit"},{"key":"2379_CR18","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.envint.2017.05.003","volume":"105","author":"A Bichteler","year":"2017","unstructured":"Bichteler A, Wikoff DS, Loko F, Harris MA. Estimating serum concentrations of dioxin-like compounds in the US population effective 2005-2006 and 2007-2008: a multiple imputation and trending approach incorporating NHANES pooled sample data. Environ Int. 2017;105:112\u201325.","journal-title":"Environ Int"},{"issue":"Suppl 12","key":"2379_CR19","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1186\/s12859-017-1818-2","volume":"18","author":"JY Shi","year":"2017","unstructured":"Shi JY, Li JX, Gao K, Lei P, Yiu SM. Predicting combinative drug pairs towards realistic screening via integrating heterogeneous features. BMC Bioinformatics. 2017;18(Suppl 12):409.","journal-title":"BMC Bioinformatics"},{"issue":"Database issue","key":"2379_CR20","doi-asserted-by":"publisher","first-page":"D1091","DOI":"10.1093\/nar\/gkt1068","volume":"42","author":"V Law","year":"2014","unstructured":"Law V, Knox C, Djoumbou Y, Jewison T, Guo AC, Liu Y, Maciejewski A, Arndt D, Wilson M, Neveu V, et al. DrugBank 4.0: shedding new light on drug metabolism. Nucleic Acids Res. 2014;42(Database issue):D1091\u20137.","journal-title":"Nucleic Acids Res"},{"issue":"125","key":"2379_CR21","doi-asserted-by":"publisher","first-page":"125ra131","DOI":"10.1126\/scitranslmed.3003377","volume":"4","author":"NP Tatonetti","year":"2012","unstructured":"Tatonetti NP, Ye PP, Daneshjou R, Altman RB. Data-driven prediction of drug effects and interactions. Sci Transl Med. 2012;4(125):125ra131.","journal-title":"Sci Transl Med"},{"issue":"2","key":"2379_CR22","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1093\/bib\/bbu010","volume":"16","author":"T Pahikkala","year":"2015","unstructured":"Pahikkala T, Airola A, Pietila S, Shakyawar S, Szwajda A, Tang J, Aittokallio T. Toward more realistic drug-target interaction predictions. Brief Bioinform. 2015;16(2):325\u201337.","journal-title":"Brief Bioinform"},{"key":"2379_CR23","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ymeth.2015.04.036","volume":"83","author":"JY Shi","year":"2015","unstructured":"Shi JY, Yiu SM, Li YM, Leung HCM, Chin FYL. Predicting drug-target interaction for new drugs using enhanced similarity measures and super-target clustering. Methods. 2015;83:98\u2013104.","journal-title":"Methods"},{"key":"2379_CR24","first-page":"512","volume-title":"BIBM. IEEE","author":"J-Y Shi","year":"2016","unstructured":"Shi J-Y, Gao K, Shang X-Q, Yiu S-M. LCM-DS: a novel approach of predicting drug-drug interactions for new drugs via Dempster-Shafer theory of evidence. In: BIBM. IEEE; 2016. p. 512\u20135."},{"issue":"Suppl 8","key":"2379_CR25","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1186\/s12859-016-1118-2","volume":"17","author":"J-Y Shi","year":"2016","unstructured":"Shi J-Y, Li J-X, Lu H-M. Predicting existing targets for new drugs base on strategies for missing interactions. Bmc Bioinformatics. 2016;17(Suppl 8):282.","journal-title":"Bmc Bioinformatics"},{"issue":"4","key":"2379_CR26","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1007\/s40484-016-0081-2","volume":"4","author":"Y Jiao","year":"2016","unstructured":"Jiao Y, Du P. Performance measures in evaluating machine learning based bioinformatics predictors for classifications. Quant Biol. 2016;4(4):320\u201330.","journal-title":"Quant Biol"},{"key":"2379_CR27","doi-asserted-by":"crossref","unstructured":"Shi J-Y, Huang H, Li J-X, Lei P, Zhang Y-N, Yiu S-M: Predicting comprehensive drug-drug interactions for new drugs via triple matrix factorization. In: IWBBIO: 2017; Spain. Lecture Notes in Computer Science: Bioinformatics and Biomedical Engineering, Springer; 2017: 108\u2013117.","DOI":"10.1007\/978-3-319-56148-6_9"}],"container-title":["BMC Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-018-2379-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12859-018-2379-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-018-2379-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T19:07:22Z","timestamp":1574190442000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcbioinformatics.biomedcentral.com\/articles\/10.1186\/s12859-018-2379-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":27,"journal-issue":{"issue":"S14","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["2379"],"URL":"https:\/\/doi.org\/10.1186\/s12859-018-2379-8","relation":{},"ISSN":["1471-2105"],"issn-type":[{"value":"1471-2105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"20 November 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"411"}}